Company intelligence / Profile preview
ProPedix
United Statespropedix.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
ProPedix is developing an innovative topical treatment for Athlete’s Foot and other fungal conditions, with a product launch expected in early 2025. The company focuses on science-backed solutions targeting dermatological health at the intersection of biopharma and consumer health. No clinical trial results are publicly available yet.[1]
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Topical compositions (pharmaceutical creams/ointments)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on ProPedix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProPedix.